Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

Hangzhou Deep Informatics Technology Co., Ltd. is a company headquartered in Hangzhou, China. The firm provides software and information consulting services. It was founded in 2017 by Kang Li and Lin Yang.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the following segments: Biopharmaceuticals, Exemplar, and Trans Ova. The Biopharmaceuticals segment is involved in advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. It also engages in pioneering a proprietary class of microbe-based biopharmaceuticals that enable expression and local delivery of disease-modifying therapeutics. The Exemplar segment is focused on developing research models and services for healthcare research applications. The Trans Ova segment provides bovine reproductive technologies. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Chiron Corporation (/ˈkaɪrɒn/ KY-ron) was an American multinational biotechnology firm based in Emeryville, California that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.

MacroGenics, Inc., a biotechnology company, focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases. The company is developing immune-based products, including monoclonal antibodies; and vaccines to prevent infections in healthy individuals. The company's Fc engineering technology enables to improve antibody functions to eliminate cancer cells. It is also developing products around the Dual Activating ReTargeting technology. The company was founded in 2000 and is headquartered in Rockville, Maryland.

Cell Targeting, Inc., a subsidiary of Lineage Cell Therapeutics, Inc., is an American company located in Cleveland, OH, that provides research and development of aqueous-based synthetic solutions. Lineage Cell Therapeutics, Inc. acquired Cell Targeting, Inc. on January 28, 2011 for $2.38 million.

W.L. Gore & Associates GmbH, part of W. L. Gore & Associates, Inc., is a company headquartered in Putzbrunn, Germany, that develops and manufactures plastic polytetrafluoroethylene and fluoroplastics. The firm was founded in 1997. Volker Gronauer, Oskar Berger and Gabriele Horski are the current co-CEOs of the company.\nThe company says this about itself: W. L. Gore & Associates is a global materials science company dedicated to transforming industries and improving lives. Founded in 1958, Gore has built a reputation for solving complex technical challenges in the most demanding environments - from revolutionizing the outerwear industry with GORE-TEX® fabric to creating medical devices that improve and save lives to enabling new levels of performance in the aerospace, pharmaceutical and mobile electronics markets, among other industries. The company is also known for its strong, team-oriented culture and continued recognition from the Great Place to Work® Institute. Headquartered in Newark, Del., Gore employs approximately 10,000 associates and generates annual revenues that exceed $3 billion.

W. L. Gore & Associates has made its name by creating innovative, technology-driven solutions, from medical devices that treat aneurysms to high-performance GORE‑TEX® fabrics. A privately held company with annual sales of more than $3 billion, Gore is committed to perpetuating its 50-plus year tradition of product innovation. Gore focuses its efforts in four main areas: electronics, fabrics, industrial and medical products. The company’s electronic products division develops and manufactures high-performance copper and optical signal transmission products. Gore’s fabrics provide protection from the elements and enable wearers to remain comfortable across a broad range of activities and conditions. The products made by Gore’s industrial division meet diverse contamination control and processing challenges throughout industry. Implants from the medical division provide creative healing solutions to complex medical problems. Today, Gore employs more than 10,000 employees, called associates, with manufacturing facilities in the United States, Germany, the United Kingdom, Japan and China, and sales offices around the world.

Manufactures vaccines for diseases like hepatitis, influenza, rubella and typhoid fever

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

AstraZeneca Investment (China) Co., Ltd., established on 2007-09-20, Business scope includes a,Invest in the pharmaceutical field and related fields that the country allows foreign investment in;two,Written entrustment by the company it invests in(unanimously approved by the board of directors),Provide the following services to its invested enterprises:1,Assist or act as an agent for the company invested by the company to purchase the machinery and equipment for the company's own use from home and abroad,Office equipment and raw materials required for production,components,Parts and sales of products produced by its invested enterprises at home and abroad,And provide after-sales service;2,With the consent and supervision of the foreign exchange management department,Balance foreign exchange among the companies it invests in;3,Provide product production for the companies invested by the company,Technical support during sales and market development,employee training,Internal personnel management and other services;4,Assist the companies it invests in seeking loans and providing guarantees;three,Establishment of scientific research and development centers or departments in China.Engaged in the research and development of new products and high-tech,Transfer of its research and development results,And provide corresponding technical services;Four,Advising its investors,Provide its affiliates with market information related to their investments,Investment policy and other consulting services;five,Undertake the service outsourcing business of its parent company and affiliated companies;six,Undertake the service outsourcing business of overseas companies;seven,Provide commodity purchase,Sales and Marketing Services;Eight,On Liangjing Road, Pudong New Area199No,245No. engaged in self-owned house rental. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Boao Biological Group Co., Ltd., established on 2000-09-30, The scope of business includes the production of instrumentation;6840In vitro diagnostic reagents,medical instruments,traditional Chinese medicine,biological reagent,Bioanalytical Instruments,biochip,Technology development of biochip accessory materials,Technical Services,Technology Promotion,technology transfer;software development;Basic software service,Application software service(Does not contain medical software);Sales instrumentation,Equipment,electronic product;Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;Import and export,Technology Import and Export,Agent import and export;Investment;investment management;lease commercial premises,office;Undertake the exhibition;Conference Services.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

At the beginning of the twentieth century, tuberculosis was one of the UK’s most urgent health problems. A royal commission, entitled The Royal Commission Appointed to Inquire into the Relations of Human and Animal Tuberculosis, was set up in 1901. It aimed to find out whether tuberculosis in animals and humans was the same disease and whether animals and humans could infect each other. This page describes how, by 1919, the Commission had evolved into the independent Medical Research Council.

BASF AB supplies raw materials to paper, chemicals, and construction industries. Its products include construction chemical, crop protection products, dispersions and pigments, plastics, polyurethane systems and coating products. The company was founded in 1953 and is headquartered in Göteborg, Sweden.

Chengdu West China Precision Medicine Industry Technology Research Institute Co., Ltd., established on 2017-05-27, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Health Consulting Services(Does not include medical services);Intellectual Property Services(Except for patent agency services);Technology intermediary service;Science popularization service;3Dprint service;business management;Corporate Headquarters Management;Production of Class I Medical Devices;Sales of Class I Medical Devices;Class I Medical Device Leasing;Sales of Class II Medical Devices;Class II Medical Device Leasing(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Class III Medical Device Leasing;Drug Clinical Trial Services(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Thread Robotics, Inc. is a company headquartered in San Jose, CA, that manufactures medical devices for fertility care. Gurjeet Singh is currently the CEO of the firm.\nThe company says this about itself: Oma Fertility, a division of Oma Robotics, was founded in 2020 by a team of engineers, AI experts, and fertility specialists who believe that combining AI and robotics in the lab and human-centered care in the clinic will make parenthood possible for more people. The company's first innovation is Oma Sperm InSight?, which uses AI to help pinpoint the most promising sperm cell for use in IVF. Oma Fertility opened its first fertility clinic in Santa Barbara, California in 2021 and has plans to expand nationally through 2023. The company was founded in 2020 by Gurjeet Singh, PhD previous founder of Ayasdi, Dr. Sahil Gupta, previous founder of Aveya Fertility, and Kiran Joshi, PhD previous founder of Koko.